Humatin Capsule
Product Images NDC 80725-250

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Humatin (NDC 80725-250). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Waylis Therapeutics Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (B8448dfd 6862 43d7 Bfa0 0937b2d16bbd 01)

Chemical structure diagram of paromomycin sulfate, the active ingredient in Humatin 250 mg oral capsules by Waylis Therapeutics LLC. The structure shows the molecular arrangement including sulfate group (H2SO4).*

FDA Label Image

Logo (B8448dfd 6862 43d7 Bfa0 0937b2d16bbd 02)

FDA Label Image

250 mg 100 Ct (B8448dfd 6862 43d7 Bfa0 0937b2d16bbd 03)

Humatin Paromomycin Sulfate Capsules, USP 250 mg, oral capsule, packaged in a bottle of 100 capsules. Label shows product name, strength, form, and directions for administration. Manufactured by Waylis Therapeutics LLC. Contains storage and handling instructions and an NDC barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.